Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

Study information

Scientific title

RAPSID: Can peer supprt, delivered as a group or individual intervention, enable people with diabetes and improve their health? A RAndomised controlled trial of Peer Support In type 2 Diabetes

Acronym

RAPSID

Study hypothesis

RAPSID is a 12 month randomised controlled study among 1200 people with Type 2 diabetes across Cambridgeshire and neighbouring counties, assessing the effect of peer support (that is support by other people with diabetes) on metabolic control (eg glucose, weight, blood pressure). Measures of self management, beliefs and quality of life will be included. The trial includes 4 groups: all receive special educational information, 25% also receive 1:1 peer support, 25% group support and 25% both group and peer support. The peers will be trained and monitored in their work and will be supported by a nurse who will link them with GP/diabetes services if needed.

The RAPSID study is based on a fully evaluated pilot which included (i) Formative evaluation in existing groups to assist with the peer support design (ii) discussions with other global groups about the design and (iii) a full pilot of the three interventions.

The Main Trial commenced with a mail survey of barriers to care to understand who volunteers to come into the trial and to identify potential peers along with an invitation to participate. Randomisation is by geographical area.